Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adherence to Hormone Therapy”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableStudy completedNCT03592771
What this trial is testing

THRIVE Breast Cancer App Study

Who this might be right for
Breast Neoplasm Female
Emory University 304
Not applicableStudy completedNCT01582334
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 68
Not applicableEnded earlyNCT05560685
What this trial is testing

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Not applicableNot Yet RecruitingNCT07759947
What this trial is testing

Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy

Who this might be right for
Hormone Receptor Positive Breast Cancer
Massachusetts General Hospital 400
Not applicableStudy completedNCT03447886
What this trial is testing

Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 17
Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Not applicableStudy completedNCT02015273
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 82
Not applicableStudy completedNCT03849573
What this trial is testing

A Web-Based Tool to Improve Breast Cancer Survivorship

Who this might be right for
Breast CancerHormone Dependent NeoplasmsAdherence to Hormone Therapy
Northwestern University 84
Not applicableWithdrawnNCT06113952
What this trial is testing

Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Pfizer
Not applicableStudy completedNCT03949270
What this trial is testing

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

Who this might be right for
Breast CancerAdherence, MedicationSide Effect
Yale University 400
Not applicableNot Yet RecruitingNCT06865755
What this trial is testing

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

Who this might be right for
Breast Cancer SurvivorBreast Cancer Early Stage Breast Cancer (Stage 1-3)
San Diego State University 15
Not applicableStudy completedNCT01400984
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 92
Not applicableStudy completedNCT01309555
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 33
Not applicableStudy completedNCT01259778
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 224
Not applicableStudy completedNCT03407768
What this trial is testing

Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer

Who this might be right for
Breast CancerPremenopausal Breast CancerHormone Receptor Positive Tumor
University of Saskatchewan 41
Not applicableEnrolling By InvitationNCT03972345
What this trial is testing

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Who this might be right for
Growth Hormone Deficiency in ChildrenBorn Small for Gestational Age
Novo Nordisk A/S 750
Not applicableStudy completedNCT01263457
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 191
Not applicableStudy completedNCT02850939
What this trial is testing

Improving Adherence to EHT Among Breast Cancer Patients

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio 108
Not applicableStudy completedNCT01555528
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 193
Not applicableStudy completedNCT01402999
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 83
Next Page